Unknown

Dataset Information

0

Aspirin-exacerbated Respiratory Disease: A Syndrome of Mast Cell-mediated PgD2 Overproduction.

ABSTRACT:

SUBMITTER: Borish L 

PROVIDER: S-EPMC6775875 | biostudies-literature | 2019 Sep

REPOSITORIES: biostudies-literature

Json Xml
altmetric image

Publications

Aspirin-exacerbated Respiratory Disease: A Syndrome of Mast Cell-mediated PgD2 Overproduction.

Borish Larry L  

American journal of respiratory and critical care medicine 20190901 6

Similar Datasets

Unknown Aspirin-Exacerbated Respiratory Disease Involves a Cysteinyl Leukotriene-Driven IL-33-Mediated Mast Cell Activation Pathway.
| S-EPMC4592820 | biostudies-literature
Unknown Omalizumab for Aspirin Hypersensitivity and Leukotriene Overproduction in Aspirin-exacerbated Respiratory Disease. A Randomized Controlled Trial.
| S-EPMC7301746 | biostudies-literature
Unknown Genetic mechanisms in aspirin-exacerbated respiratory disease.
| S-EPMC3151506 | biostudies-literature
Unknown Perimenstrual Asthma in Aspirin-Exacerbated Respiratory Disease.
| S-EPMC7012664 | biostudies-literature
Unknown Inflammatory heterogeneity in aspirin-exacerbated respiratory disease.
| S-EPMC8035132 | biostudies-literature
Unknown Platelets in patients with aspirin-exacerbated respiratory disease.
| S-EPMC4559084 | biostudies-literature
Unknown Biomarkers for predicting response to aspirin therapy in aspirin-exacerbated respiratory disease.
| S-EPMC9292205 | biostudies-literature
Unknown Plasma tryptase elevation during aspirin-induced reactions in aspirin-exacerbated respiratory disease.
| S-EPMC6519056 | biostudies-literature
Unknown Automated identification of an aspirin-exacerbated respiratory disease cohort.
| S-EPMC5266739 | biostudies-literature
Unknown Appropriate extent of surgery for aspirin-exacerbated respiratory disease.
| S-EPMC7729211 | biostudies-literature